A phase I study of belantamab mafodotin in combination with standard of care in newly diagnosed multiple myeloma: An interim analysis of DREAMM-9 Meeting Abstract
| Authors: | Leypoldt, L.; Usmani, S. Z.; Mielnik, M.; Byun, J. M.; Alonso, A.; Abdallah, A. O.; Garg, M.; Quach, H.; Min, C. K.; Janowski, W.; San Miguel, E. M. O.; Weisel, K.; Oriol, A.; Sandhu; Rodriguez-Otero, P.; Ramasamy, K.; Egger, J. L.; Williams, D.; Ma, J.; Kaisermann, M. C.; Hus, M. |
| Abstract Title: | A phase I study of belantamab mafodotin in combination with standard of care in newly diagnosed multiple myeloma: An interim analysis of DREAMM-9 |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (2023) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 46 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Oct 13-16 |
| Meeting Location: | Hamburg, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2023-10-01 |
| Start Page: | 181 |
| End Page: | 182 |
| Language: | English |
| ACCESSION: | WOS:001091456900388 |
| PROVIDER: | wos |
| PUBMED: | 37788643 |
| DOI: | 10.1159/000533576 |
| Notes: | Meeting Abstract: P338 -- Source: Wos |
